<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01820949</url>
  </required_header>
  <id_info>
    <org_study_id>380/12</org_study_id>
    <nct_id>NCT01820949</nct_id>
  </id_info>
  <brief_title>Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients</brief_title>
  <acronym>PBM</acronym>
  <official_title>Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Bonn</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vifor Pharma</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>B. Braun Melsungen AG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>CSL Behring</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fresenius Kabi</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate clinical outcome after the step-wise implementation of a Patient
      Blood Management (PBM) Program in surgical patients at 4 hospitals.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A PBM program will be implemented stepwise in four University Hospitals, with the intention
      to optimize preoperative hemoglobin concentration of patients and to standardize transfusion
      practice within hemotherapy. The PBM program includes 1) an algorithm with the aim to correct
      preoperative anemia in elective surgery, 2) a strict indication for the transfusion of red
      blood cells defined by the &quot;Cross-sectional Guidelines for Therapy with Blood Components and
      Plasma Derivatives&quot; for all surgical patients, and 3) a perioperative checklist for different
      blood-sparing techniques (e.g. cell-saver, normothermia, reduced blood samples, point-of-care
      diagnostics for bedside coagulation management).

      Primary endpoint: Safety of the use of PBM program will be determined by comparability of the
      composite outcome (in-hospital myocardial infarction, stroke, acute renal failure, death of
      any cause, pneumonia and sepsis until discharge from hospital) between patients treated after
      implementation and patients treated before implementation (control cohort) of the PBM
      program.

      The primary composite endpoint defined as described above will be registered electronically
      by analysis of Diagnosis Related Groups (DRG) codes. The frequency of these events will be
      compared between PBM and control cohort stratified by center with a one-sided Mantel-Haenszel
      test in a non-inferiority setting with significance level of α=2.5% and a non-inferiority
      margin of 1% for the incidence of the composite endpoint.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Myocardial infarction, stroke, acute renal failure, death of any cause, pneumonia and sepsisComposite outcome</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 2 weeks</time_frame>
    <description>Composite endpoint defined as in-hospital myocardial infarction, stroke, acute renal failure, death of any cause, pneumonia and sepsis until discharge from hospital</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of stay on the intensive care unit</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total hospital stay</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total number of red blood cell transfusions during hospital stay</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consumption of coagulation factors</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 2 weeks</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">110000</enrollment>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Control cohort</arm_group_label>
    <description>Standard care before implementation (pre-implementation)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PBM cohort</arm_group_label>
    <description>After implementation of PBM program (post-implementation)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        all surgical patients over a period of 24 months at 4 hospitals
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All non- ambulant, surgical, anesthetized patients (≥18 years)

          -  General Surgery, Cardiac Surgery, Thoracic Surgery, Trauma Surgery, Vascular Surgery,
             Urology, Gynecology, Otolaryngology, Neurosurgery, Crania-Maxillofacial Surgery

        Exclusion Criteria:

          -  ambulant and all non-surgical anesthetic procedures

          -  Surgery in the field of Dermatology or Ophthalmology
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kai Zacharowski, MD, PhD, FRCA</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital, Frankfurt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrick Meybohm, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Frankfurt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Erhard Seifried, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>German Red Cross Blood Service Baden-Württemberg-Hessen, Institute for Transfusion Medicine and Immunohematology of the Goethe University Hospital, Frankfurt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eva Herrmann</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Biostatistics and Mathematical Modeling, Goethe University Frankfurt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Bonn</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Schleswig-Holstein</name>
      <address>
        <city>Kiel</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Muenster</name>
      <address>
        <city>Muenster</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.biomedcentral.com/content/pdf/s12913-014-0576-3.pdf</url>
    <description>Safety and effectiveness of a Patient Blood Management (PBM) program in surgical patients - the study design for a multi-centre prospective epidemiologic non-inferiority trial</description>
  </link>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2013</study_first_submitted>
  <study_first_submitted_qc>March 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2013</study_first_posted>
  <last_update_submitted>September 4, 2015</last_update_submitted>
  <last_update_submitted_qc>September 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johann Wolfgang Goethe University Hospital</investigator_affiliation>
    <investigator_full_name>Professor Kai Zacharowski, M.D., Ph.D., FRCA</investigator_full_name>
    <investigator_title>Prof. Dr. Dr. Kai Zacharowski</investigator_title>
  </responsible_party>
  <keyword>patient blood management</keyword>
  <keyword>patients safety</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

